Xickle® RBC-Plus™ is available now. WHY WAIT. Live a Healthier Life!
Connect With Us

THE PRODUCT

The New and Improved Xickle® RBC-Plus™ has now been shown to be a promising new drug for the treatment of sickle cell disease. Just read the paper presented at the ASH conference for SCD-101, the drug equivalent of Xickle® RBC-Plus™.

The New and Improved Xickle® RBC-Plus™, with clove, pepper and sorghum, is a system to protect the structural integrity of red blood cells from shape distortion, damage or destruction from certain red blood cell conditions like sickle cell disease that produce episodes of low blood oxygen (hypoxic conditions) that can happen unexpectedly and particularity during vigorous exercise.

Xickle® RBC-Plus™ can also reduce red blood cell clumping that can obstruct blood cell flow and can therefore guard against the side effects of the release of toxic constituents during red blood cell death.

Learn More About Xickle®

Xickle® RBC-Plus™ is your primary defense against the day-to-day environmental hazards that can decrease and degrade the ability of your red blood cells to supply life-giving oxygen to every cell in your body. Xickle® RBC-Plus™ guards against those agents that can distort red blood cells and cause them to clog blood vesicles and cause pain and organ degeneration and possible organ failure.

  • Your best defense against those conditions that damage the integrity and function of your red blood cells.
  • Completely natural and safe.
  • Effective for all ages, but specially formulated for individuals under the age of 18.
  • Proved in clinical studies.
  • Your best defense against red blood cell damage.
  • Try it now. WHY WAIT

Questions / Comments

If you have questions or comments about Xickle® RBC-Plus (the supplement equivalent of SCD-101), please fill out the form below and a representative will be in touch.

Sign Up For Xickle's Newsletter!

Get the latest news, health tips and special offers!








Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!